Six monoclonal antibodies (mAbs) against lipopolysaccharides (LPS) from Bordetella pertussis (PI P3, 60.5), B. parapertussis (PP2, PP6, PP8) and B. bronchiseptica (BRgl) were used t o examine the presence of antigenic determinants of LPS on B. bronchiseptica cells. Forty-eight clinical isolates of this Gram-negative bacterium (4 canine, 3 equine, 6 porcine, 4 rabbit and 31 human) were examined. Significant cross-reactivities with the heterologous anti-pertussis and anti-parapertussis mAbs were observed. The isolates also exhibited marked antigenic polymorphism. The 48 isolates could be classified in six immunogroups. Purified LPS preparations extracted from some isolates were analysed by ELISA, thin-layer chromatography, and tricine-SDS-PAGE. The results show that four main types of antigenic polymorphism of B. bronchiseptica LPSs exist: (a) heterogeneity of the core, (b) presence or absence of O-chains, (c) differences in the hinge region between O-chain and core, and (d) differences in interactions of LPS with other cell-surface constituents. Smooth-type LPS molecules, detectable with mAb PP6, were more frequently observed in animal isolates (94%) than in human isolates (52%). Reverse frequencies were found with mAb 60.5 (48% of human isolates, 18% of animal isolates), which is unable t o react with long-chain LPSs. This observation could be due t o the general absence of some lectin-like receptor, specific t o the O-chain, on human bronchoalveolar tissues.
INTRODUCTION
Bordetella bronchiseptica is a Gram-negative bacterium which usually causes disease in rabbits (Deeb et al., 1990 ) and wild animals. It is also the agent of a highly contagious form of tracheobronchitis in dogs (Ghosh et al., 1979) , and one of the agents of atrophic rhinitis in swine. Although the organism is generally associated with animal diseases, there have recently been increasing numbers of reports of B. bronchiseptica in immunocompromised human hosts (Amador et al., 1991; Bauwens et al., 1992; Buggy et a!., 1987; Meis et al., 1990; Stoll et al., 1981; Mesnard et al., 1993; Ng et al., 1992) .
Many studies dealing with bronchiseptica infections have focused on protein antigens such as fimbriae (Blom et al., 1983) , pertactin (Novotny et al., 1985) , adenylate cyclase-haemolysin (Gueirard & Guiso, 1993) , filamentous haemagglutinin, dermonecrotic toxin and tracheal cytotoxin (Cookson & Goldman, 1987) , but little work has been done on another major cell-surface component, the lipopolysaccharide (LPS). LPSs from B. bronchiseptica have an O-antigen structure consisting of repeating units of 2,3-dideoxy-2,3-di-N-acetylgalactosaminuronic acid (2,3-diNAcGalA) (Di Fabio et al., 1992) . Bordetella pertussis, the human pathogen, agent of whooping cough, expresses an LPS lacking this repetitive O-antigen structure (Chaby & Caroff, 1988) , whereas the other human pathogen belonging to the same genus, B. parapertussis, expresses O-chains similar to those of B. bronchiseptica (Di Fabio et al., 1992) .
Recently, we demonstrated that humans can be infected with B. bronchiseptica after contact with infected animals (Gueirard et al., 1995) . Furthermore, we observed that B. bronchiseptica may persist for more than 2 years inside the host. The analysis of the LPSs of the different human isolates collected during this 2 year period showed that the first isolate possesses both K. L E BLAY a n d O T H E R S smooth and rough-type molecules whereas the last one expresses an LPS similar to that of B. pertussis, i.e.
consisting of short-chain molecules only (P. Gueirard and co-workers, unpublished) . This structural variation of its LPS may be one of the means by which B. bronchiseptica evades the host immune responses. A similar strategy has been observed with Neisseria gonorrhoeae (Rude1 et al., 1992) and several other pathogens (Brunham et al., 1993) .
Only moderate variations of the LPSs of B. pertussis and B. parapertussis (Porter et al., 1995) have been described so far. The assumed presence of a single type of 0-antigen chain in both B. parapertussis and B. bronchiseptica (Di Fabio et al., 1992) could lead to the conclusion that only very small antigenic variations of the LPS components should also be observed in B. bronchiseptica. However, this assumption is based on the analysis of a very limited number of B. bronchiseptica strains (Di Fabio et al., 1992) . This problem was thus re-examined in the present study, by the analysis of a large number of human and animal clinical isolates of B. bronchiseptica. The LPS antigens present on these cells were analysed with a panel of monoclonal antibodies (mAbs) directed against various epitopes of Bordetella LPSs, which have been previously characterized (Le Blay et al., 1994 , 1996 Porter et al., 1995) .
METHODS
Bacterial strains and growth conditions. A total of 48 B. bronchiseptica isolates was examined: 4 canine (c), 3 equine (e), 4 rabbit (r), 6 porcine (p), and 31 human (h) isolates.
Bacteria were grown for 48 h on Bordet-Gengou agar (BGA) supplemented with 15 '/o (v/v) defibrinated sheep blood, then suspended in saline to an OD,,, of 2 and heated at 100 "C for 15 min.
Chemicals and reagents. Polyoxyethylene-sorbitan monolaurate (Tween 20), horseradish-peroxidase-labelled goat antimouse Ig, and the peroxidase substrates o-phenylenediamine dihydrochloride and 3,3'-diaminobenzidine, were from Sigma. Polyisobutyl methacrylate was from Aldrich. Gelatin was from Rousselot Kuhlmann. Polyethylene glycol 1500 was from Boehringer Mannheim.
Monoclonal anti bodies. The preparation and characterization of the mAbs PP6, PP8, BRgl, PlP3, and 60.5 have been described previously (Le Blay et al., 1994 , 1996 Porter et al., 1995) . mAb PP2 was produced by a hybrid cell line isolated after the same immunization and cell fusion which gave rise to mAb PP6. The specificities of the antibodies are indicated in Table 1 .
Lipopolysaccharides. The LPSs used in this study were extracted and purified from B. pertussis strain 1414 (standard LPS), and from B. bronchiseptica isolates 9.73H + (r), LAPR (r), R1 (h), R2 (h) and R3 (h), as described previously Chaby & Caroff, 1988; P. Gueirard and coworkers, unpublished) . Briefly, LPSs 9.73H + , LAPR, R1 and R2 were extracted by the enzyme/phenol/water method (Johnson & Perry, 1976) , and LPS R3 by the phenol/ chloroform/petroleum ether (PCP) method (Galanos et al., 1969) . All LPS preparations were devoid of protein contamination as assessed by the absence of protein bands when analysed by SDS-PAGE with Coomassie blue staining. ELISA. Reactivities of mAbs with bacteria or purified LPSs were determined by ELISA. The 96-well Immulon-A plates (Greiner Labortechnik) were coated with 100 pl heat-killed bacterial suspensions in saline, or with 100 p1 purified LPS (20 pg ml-l) in a buffer (pH 9-6) consisting of 50 mM Tris/HCl and 20 mM MgC1,. After overnight incubation at 20 "C with mild stirring, the unbound antigen was washed away with 0.1% Tween 20 in PBS (Tween buffer), and the plates were incubated for 1 h at 37 "C with 0.25% gelatin in the same buffer. The plates were rewashed with this solution and the sample of mAb (150 pl, 1 : 1000 dilution in the same solution) added to each well. After incubation for 2 h at 37 "C, the plates were washed with the Tween buffer, and the peroxidaselabelled goat anti-mouse Ig reagent added. After incubation at 37 "C for 90 min, the plates were washed and developed by adding 100 pl of a freshly prepared solution of o-phenylenediamine (0-5 mg ml-l) in 0.05 M phosphate/citrate buffer (pH 5 ) containing sodium perborate (0.03%) as a substitute for hydrogen peroxide. After 15 min at room temperature, the reaction was stopped with a solution of 0.5 '/o sodium sulfite in 1 M H,SO, (50 pl per well). The plates were scanned at 490 nm in a Dynatech MR 5000 spectrophotometer. Reactions with absorbances higher than 0-3 were scored as positive. Thin-layer chromatography (TLC) and immunostaining. TLC of LPSs (1-2 pg per lane) was carried out on Silica gel 60 ( 0 2 mm on aluminium foil; Merck) in isobutyric acid/l M ammonium hydroxide (5 :3, v/v) . LPS bands were revealed by heating (120 "C) the plates with 10% (v/v) sulfuric acid in ethanol. For immunostaining, the plates were dried after chromatography, and dipped for 3 min in a solution of polyisobutyl methacrylate (0.1% in hexane/ chloroform; 97:3, v/v). The plates were dried again and saturated (1 h, 37 "C) with low-fat lyophilized milk (5 '/o, w/v, in PBS). After three washings (5 min, 20 "C, with mild stirring) in a washing buffer consisting of milk (5 '/o, w/v) and Tween 20 (0.1 %) in PBS, the plates were overlaid with one of the anti-LPS mAbs (1 : 1000 dilution of ascitic fluid), incubated for 2 h at 37 "C with gentle shaking, and washed (three times, 5 min each) with the washing buffer. Enhanced chemiluminescence detection, using luminol as a substrate for peroxidase, was done by incubating the plates for 1 min in RENAISSANCE reagent (DuPont NEN), covering with a protector plastic sheet, and exposing for 20-120 s to DuPont REFLEXION film. TSDSPAGE. LPSs were separated by polyacrylamide gel electrophoresis according to the protocol of Schagger & Von Jagow (1987), as modified by Lesse et al. (1990) . This methodology, known as tricine-sodium dodecyl sulfatepolyacrylamide gel electrophoresis (TSDS-PAGE), uses tricine (pK 8.15) in the cathode buffer in place of glycine (pK 9*6), with a marked increase in resolution of low-molecular-mass proteins (Schagger & Von Jagow, 1987) and LPSs (Lesse et al., 1990) . LPS bands were fixed overnight in 40 '/o ethanol/5 '/o acetic acid solution and silver-stained according to the method of Tsai & Frasch (1982) . Statistical analyses. Pearson correlation coefficients (C,), probabilities (P) associated with each coefficient, and cluster analysis of the 48 B. bronchiseptica isolates, were computed with the SYSTAT software (Systat Inc.). Results of cluster analysis were visualized by a neighbour-joining dendrogram. Neighbouring was based on C, determined for six parameters consisting of the ELISA reactivities with the mAbs PlP3,60.5, PP2, PP6, PP8 and BRgl. The measure of distance was 1 -C,. The single-linkage method (nearest neighbour) (Hartigan, 1975) each mAb used. The mAb BRgl specific to B. bronchiseptica recognized only 50 '/o of the bacterial suspensions, thus confirming our preliminary data (P.
Gueirard and co-workers, unpublished), indicating that the B. bronchiseptica LPS structure varies. However, it should be noted that 15 out of 17 B. bronchiseptica isolates of animal origin were recognized by a mAb (PlP3) specific to the core epitope of the three Bordetella species and by a mAb (PP6) specific to the 0-chain, indicating that 88% of these animal isolates possess a smooth-type LPS with accessible core and 0-chain epitopes, whereas only 23 YO (7 out of 31) of the isolates of human origin were recognized by the same mAbs.
Classification of the strains into different antigenbased phenotypes
A simple classification of the strains according to their ELISA reactivities can be obtained with three discriminative criteria : reactivity with mAb P1P3 (anti-B. overlaid by a 4 % stacking gel (0.5 cm). Electrophoresis was carried out (6 h, 110 V) in the tricine/SDS buffer system, and LPS bands were visualized by silver staining.
pertussis), reactivity with mAb PP6 (anti-B. parapertussis), and reactivity with mAb BRgl (anti-B. bronchiseptica). The result (Table 2) shows a classification of the isolates into six immunogroups (two of the eight theoretically possible patterns of reactivities were not represented). It is noteworthy that only 23 of the B. bronchiseptica isolates (groups C1 and C2) reacted with the anti-B. bronchiseptica mAb BRgl, whereas 2.5 isolates (groups Al, A2, B1, B2) did not. Another classification of the isolates was generated by computer analysis of ELISA data. The result, expressed as a neighbour-joining dendrogram (Fig. 3) , shows a classification very similar to that proposed in Table 2 . All isolates belonging to a given immunogroup were located at vicinal positions in the dendrogram.
Reactivities of the mAbs with purified LPSs from selected isolates
In order to analyse further the variability of the LPS epitopes detected on the different isolates, we used the LPSs of the two rabbit (9.73H+, LAPR) and three human ( R l , R2, R3) isolates of B. bronchiseptica belonging to four different immunogroups (B2, C2, A2 and Al). TSDS-PAGE analysis of the purified LPSs (Fig.   4) number of rough-type molecules, and their migrations, were different in the five LPS preparations. Four sharp lmmunostaining of LPS bands with mAbs PIP3 and 60.5 after TLC bands of rough-or semi-roughltype LPS molecules were observed in the 9.73H+ preparation, only one fastmigrating molecule was detectable in the R3 preparation, and more diffuse bands were detectable in the R1, R2 and LAPR preparations.
The antigenic features of the five preparations of B. bronchiseptica LPSs were analysed by ELISA with five of the mAbs used above (PP6, PP8, BRgl, 60.5 and PlP3), and were compared to those of a B. pertussis LPS, which have been characterized in a previous study (Le Blay et al., 1996) . The results (Fig. 5 ) were generally consistent with those obtained with the corresponding bacterial suspensions (Figs 1 and 2 ). However, a few differences were apparent: (i) mAb 60.5 reacted with the LPS preparations isolated from the rabbit strains LAPR and 9.73H+, but did not react with the corresponding bacterial suspensions; and (ii) mAb P1P3 reacted with the LPS isolated from the human strain R3, but did not react with the corresponding bacterial suspensions. These differences are probably due to the inaccessibility of the corresponding LPS epitopes in the cell-surface environment, and may reflect the existence in some isolates of associations of LPS with other cell surface molecules that can hinder the interaction with the anti-LPS antibody.
We have shown in a previous study (Le Blay et al., 1994) that the reaction between LPS and mAbs PP6, PP8 and BRgl requires the presence of 0-chains. This means that these mAbs cannot be used for the analysis of the lowmolecular-mass (rough-type) LPS molecules. On the other hand, mAbs P1P3 and 60.5 react with epitopes present in the B. pertussis LPS, which is devoid of 0-chain, but their ability to interact with some smoothtype LPS molecules was unknown. In order to determine if the differences in reactivities observed with these antibodies reflect a heterogeneity of the short-chain LPS molecules exclusively, or if they can also be attributed to long-chain LPSs, we analysed by TLC (immunostained with the mAbs) the two LPS preparations containing smooth-type molecules (from 9.73H + and LAPR). TLC allows a rapid separation of short-and long-chain LPS molecules . When LPS bands were detected by charring with sulfuric acid (Fig. 6a) , we found that both 9.73H+ and LAPR preparations contained smooth-type LPS molecules (remaining on the baseline of the TLC plate), semi-rough type molecules (RF 0.39), and rough-type LPS molecules (RF 0-53-0.57).
Immunostaining of the plates with mAbs P1P3 and 60.5 indicated that in the two LPS preparations, only smoothand semi-rough-type molecules are detectable with and its associated probability (P = 0.002) were computed with SYSTAT. mAb P1P3 (Fig. 6b) , and only semi-rough molecules are detectable with mAb 60.5 (Fig. 6c) . mAb P1P3 can react with long-chain molecular species, whereas mAb 60.5 cannot. Since the epitope recognized by mAb 60.5 is located in a distal trisaccharide of the B. bronchiseptica LPS (Le Blay et al., 1996) , the absence of reactivity of long-chain LPSs with mAb 60.5 may be due either to the absence of the distal trisaccharide in these molecules (the trisaccharide may block the biosynthetic attachment of the 0-chain), or to a modification of the structure and/or the accessibility of the epitope by the 0-chain.
The observation that the long-chain LPSs from the two rabbit isolates 9.73H+ and LAPR did not react with mAb 60.5 (Fig. 6c) probably reflects a general phenomenon characteristic of all long-chain LPSs of B. bronchiseptica. Indeed, when ELISA data obtained with the 28 isolates reactive with mAb 60.5 were re-examined, we found that the reactivities of these bacteria with mAb PP6 (exclusively due to the presence of long-chain LPSs) were inversely correlated with their reactivities with mAb 60.5 (C, = -0.558; P = 0.002) (Fig. 7) .
DISCUSSION
Bordetella bronchiseptica is mainly an animal pathogen, but infections of humans with this micro-organism have also been described (Bauwens et al., 1992; Gueirard et al., 1995) . In humans, B. bronchiseptica is an opportunistic bacterium, but can be pathogenic, especially in severely immunocompromised subjects (Woolfrey & Moody, 1991) . This bacterium was shown recently to be able to persist for rather long periods in its host (Gueirard et al., 1995) , which provides optimal conditions for variation. Another feature which favours variation (Monack et al., 1989) is the high adaptability of this micro-organism to its environment. Unlike B. pertussis and B. parapertussis, which require stringent culture conditions (Regan & Lowe, 1977) , B. bronchiseptica can be isolated from natural waters such as lakes, and can even grow in buffered saline without added nutrients (Porter et al., 1991) .
This adaptability of B. bronchiseptica may explain its variability, and the marked antigenic polymorphism of its LPS observed in this study. With the set of anti-LPS mAbs that we used, we were able to detect at least six major antigenically distinct groups in the 48 isolates analysed (Table 2, Fig. 3 ). It should be noted that this classification reflects the accuracy of the tool used to define it; the variability of the LPS could well appear even greater in the future if other specific antibodies can be produced.
Various factors may explain the overall variations in the reactivities of the cells with mAbs found in the first part of this study. One possibility, unrelated to LPS itself, is expression on the cell surface of proteins able to reduce LPS accessibility. A second possibility is variation in LPS accessibility due to modifications of the LPS itself, such as the addition of a sugar side-chain in the vicinity of the recognized epitope, which could hinder its accessibility to the antibody. The third possibility is a structural modification within the LPS epitope, provided by the addition of a new substituent, or by the new location of a pre-existing one. It was therefore important to reexamine the variations in reactivities with mAbs at the level of purified LPSs rather than on whole cells. For that purpose we selected five isolates that were shown previously to express distinct LPSs. Three of these isolates (Rl, R2, R3), of human origin, were collected from the same patient over a period of 2 years; one isolate (LAPR) was collected from an infected rabbit which was the source of the patient's infection, and one isolate (9.73H + ) was from another, unrelated, K. LE B L A Y a n d OTHERS isolated from these strains were detectable by TSDS-PAGE (Fig. 4) . The two LPS preparations obtained from rabbit isolates (9.73H + and LAPR), shown previously to be antigenically different (P. Gueirard and coworkers, unpublished) , contained rough-, semi-rough-, and smooth-type LPS molecules, whereas the three LPS preparations obtained from the human isolates (Rl, R2, R3) did not contain the high-molecular-mass (smoothtype) molecules. This absence of smooth-type LPSs appeared to be rather frequent in human isolates, since long-chain LPSs were detectable (with mAb PP6) in only 52% of the human isolates analysed in this study, whereas 94 % of the animal isolates contained molecules of that type. In connection with this result, 48% of the isolates of human origin are recognized by mAb 60.5, specific to the distal trisaccharide, as compared to only 18% of the isolates of animal origin. This inverse correlation between the reactivities of PP6 and 60.5 (Fig.  7 ) is due to the inability of the latter to react with longchain LPSs (Fig. 6) . On the other hand, when isolates from different animal species (dogs, horses, rabbits, pigs) were compared, we did not find significant differences in their patterns of reactivity with the mAbs. The high variability of the LPSs from isolates of human origin could be due to the fact that B. bronchiseptica persists inside the host and might change its LPS structure in order to evade the immune response. This suggests that a B. bronchiseptica isolate of human origin expressing an LPS with an 0-chain may correspond to a primary infection, whereas a B. bronchiseptica isolate expressing exclusively rough-type LPS molecules may correspond to a recurrent or chronic infection. The change in LPS structure might be due to the fact that there is no lectin-like receptor specific to the 0-chain on human bronchoalveolar tissues, and that the B. bronchiseptica LPS must vary to enable the persistence of the bacteria in their host. All these data suggest for the first time an important role for the LPS in B. bronchiseptica pathogenesis. The fact that only one isolate of animal origin does not possess an 0-chain in its LPS suggests either that B. bronchiseptica does not persist inside animals, or that susceptible animals possess specific receptors for smooth-type LPSs. This could be related to differences in the adherence of this bacterium to human versus non-human ciliated respiratory epithelial cells (Tuomanen et al., 1983) . However, it should be noted that the presence or absence of 0-chains is not the sole type of variation since differences in LPS were also found in isolates of animal origin.
Another major source of LPS variability was detected with mAbs PP6, PP8 and BRgl. As summarized in Table   1 , these three antibodies react exclusively with LPSs containing the repeating unit (2,3-diNAcGalA) of the 0-chain. However, mAbs PP8 and BRgl also require the presence of structural elements of the core, whereas PP6 does not. The results in Fig. 5 show that mAb PP6 reacts with the two LPSs in which 0-chains are present (9.73H + and LAPR) whereas mAbs PP8 and BRgl react only with LAPR. This observation suggests that a common 0-chain is indeed present in both LAPR and 9.73H+ LPSs, but that the junction point of this chain to the core is different. This is probably the major difference between immunogroups B (Bl, B2) and C (Cl, C2). This confirms our preliminary results obtained with sera from infected hosts (P. Gueirard and coworkers, unpublished ).
An additional source of antigenic heterogeneity of B. bronchiseptica is detectable with mAb PlP3. The epitope recognized by this antibody is located in the inner core region (Le Blay et al., 1996) . Therefore, mAb P1P3 reacts with all purified preparations of Bordetella LPSs (Fig. 5 ) , including long-chain LPSs (Fig. 6) . However, this antibody does not react with the isolates belonging to immunogroups B1 and C1, although longchain LPSs are detectable (with mAb PP6) in these bacterial suspensions. This means that the epitope recognized by PlP3, although present, is not accessible on the surface of the bacteria. This is clearly observed with the R3 isolate, in which the LPS is detectable with mAb P1P3 only after extraction and purification (Fig. 5) . This phenomenon is probably due to interactions between the core epitope and other cell-surface constituents present in some isolates.
In conclusion, four main types of variation of the B. bronchiseptica LPS are apparent : (a) heterogeneity of the core, (b) presence or absence of 0-chains, (c), differences at the level of the hinge region between the 0-chain and the core, and (d) differences in the association with other cell-surface constituents. It should be noted that differences at the hinge region between core and 0-chains might be due to heterogeneity of the core itself, which is suggested by the pattern of bands in the 9.73H+ LPS (Fig. 4) . These conclusions are based on immunological, chromatographic and electrophoretic analyses of the LPSs ; their confirmation will require further structural studies.
